Herpes Serology: HSV-1 and HSV-2 Type-Specific Diagnosis from the Public Health Perspective

SPONSORED BY: DiaSorin
Speakers
  • Director, Public Health Laboratory, State of Tennessee Department of Health
    Biography
      Dr. Richard Steece is certified as the Public Health Laboratory Director at the State of Tennessee Department of Health. He came into this role with over 30 years of experience and is one of the nation's leading public health laboratory experts. Among his multiple admirable roles driving public health initiatives, Dr. Steece has recently served as the National Chlamydia Laboratory Coordinator for the Centers for Disease Control and Prevention (CDC) and as Science Advisor to the Association of Public Health Laboratories (APHL). Most recently, Dr. Steece is the incoming chair of the 2015 STD subcommittee for APHL, and he is continuing this appointment into 2016. Prior to his public health career working with every city, county and state public health laboratory in the US, Dr. Steece earned his PhD in Biology/Microbiology.

    Abstract:

    Serology testing continues to be an indispensable tool for the management of several disease states, especially for the qualitative determination IgG antibodies to Herpes simplex virus Type 1 (HSV-1) or Herpes simplex virus Type 2 (HSV-2) in human serum.
     
    Come to this educational seminar to learn about key objectives in HSV-1 or HSV-2 type-specific diagnosis:

    • Examine how serology assays may be indicated in certain clinical scenarios: in sexually active adults or expectant mothers to aid in the presumptive diagnosis of HSV-1 or HSV-2 type-specific infection.
    • Discuss the US clinical guidelines regarding why HSV-1 and HSV-2 type-specific screening is not indicated in the general US population as it is for other STDs.
    • Describe diagnostic methods for diagnosing HSV-1 or HSV-2 type-specific infection: the differences between virologic and serologic assays and their usefulness in herpes diagnosis.

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    Loading Comments...
    Show Resources